Enhanced Enzyme-like Activity in Bimetallic Cu-Co Prussian Blue Analogues: Highly Sensitive Glucose Detection and Efficient Antibacterial Applications

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Recent years have witnessed growing focus on bimetallic Prussian blue analogs (PBAs) within the cross-disciplinary research areas of materials science and biomedicine. These materials possess a range of favorable properties, including an open framework structure, inherent catalytic activity, excellent biocompatibility, and tunable structural characteristics. Within the current research, a Cu–Co bimetallic Prussian blue analogue (Cu–Co PBA) with a characteristic framework structure was effectively fabricated via a straightforward low-temperature co-precipitation approach. Owing to its cost-effectiveness, high stability, straightforward preparation, and the synergistic interaction between Cu 2+ and Co 2+ ions, Cu–Co PBA shows significant potential as a multifunctional nanozyme and catalytic material. The catalyst demonstrates exceptionally high peroxidase-mimicking activity as a result of the synergistic interaction between the coexisting Cu + /Cu 2+ and Co 2+ /Co 3+ redox pairs within the system. This synergy facilitates electron transfer and remarkably boosts the catalytic decomposition efficiency of H₂O₂. Cu–Co PBA shows catalytic activity several times higher than single Cu-PBA or Co-PBA, thus improving glucose detection sensitivity and accelerating response kinetics, with a linear detection range of 10 µM–2000 µM and a low limit of detection of 2 µM. Moreover, Cu–Co PBA nanoparticles achieve efficient chemodynamic antibacterial performance by catalyzing H₂O₂ to produce hydroxyl radicals (·OH), which destroy bacterial cell structures and endow broad-spectrum antimicrobial activity. The inhibition rates for Staphylococcus aureus and Escherichia coli are 99.05% and 98.92%, respectively. This work integrates glucose detection and antibacterial treatment through the enzyme-like and Catalytic performance of bimetallic Prussian blue nanozymes, offering a promising multifunctional platform for biomedical applications.

Article activity feed